Iterum Therapeutics plc (ITRM) |
|
3.03 0.09 (3.06%)
|
02-20 16:00 |
|
Open: |
3 |
Pre. Close: |
2.94 |
|
High:
|
3.41 |
Low:
|
2.86 |
|
Volume:
|
112,386 |
Market Cap:
|
45M |
|
|
|
|
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was founded in 2015 and is headquartered in Dublin, Ireland. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.414 - 3.427 |
3.427 - 3.44 |
|
Low:
|
2.83 - 2.844 |
2.844 - 2.857 |
|
Close:
|
3.007 - 3.029 |
3.029 - 3.051 |
|
Technical analysis |
as of: 2020-02-20 4:41:09 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 4.42 One year: 5.55 |
| Support: |
Support1: 2.22 Support2: 1.85 |
| Resistance: |
Resistance1: 3.78 Resistance2: 4.75 |
| Pivot: |
2.58  |
| Moving Average: |
MA(5): 2.78 MA(20): 2.60
MA(100): 3.28  MA(250): 5.41 |
| MACD: |
MACD(12,26): -0.12 Signal(9): -0.20 |
| Stochastic oscillator: |
%K(14,3): 77.60 %D(3): 77.12 |
| RSI: |
RSI(14): 54.28 |
| 52-week: |
High: 9.30 Low: 1.68 Change(%): -46.0 |
| Average Vol(K): |
3-Month: 32999 10-Days: 6599 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ITRM has closed It is unclear right now based on current numbers. 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ITRM's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 17 Jan 2020 14:14:23 +0000
Health Care Sector Update for 01/17/2020: DRRX, ITRM, LLY, JNJ, PFE, ABT, MRK, AMGN
Wed, 11 Dec 2019 01:28:55 +0000
FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch
Wed, 04 Dec 2019 01:38:26 +0000
Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch
Thu, 31 Oct 2019 05:30:20 +0000
Top 5 Losers In Healthcare Sector (CYCN, AMAG, ELGX…)
Mon, 25 Mar 2019 16:32:38 +0000
Mid-Day Market Update: Iterum Therapeutics Gains After Q4 Results; Proteostasis Therapeutics Shares Slide
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
14.42 |
| Shares Float (M) |
4.99 |
|
% Held by Insiders
|
3.58 |
|
% Held by Institutions
|
72.96 |
|
Shares Short (K)
|
277 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-7.302 |
|
Book Value (p.s.)
|
-0.210 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-37241.31 |
|
Return on Assets (ttm)
|
-76.6 |
|
Return on Equity (ttm)
|
-228.0 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.060 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-7.118 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-82.69 |
|
Levered Free Cash Flow (M)
|
-43.21 |
Stock Valuations |
|
P/E
|
-0.41 |
|
P/E Growth Ratio
|
0.03 |
|
P/BV
|
-14.43 |
|
P/S
|
151.50 |
|
P/CF
|
-0.53 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
